Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN103896816B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103896816B details iridium-catalyzed synthesis offering high enantioselectivity and scalable production for pharmaceutical intermediates.